Following the agreement between the Poctefa Management Authority and the coordinators, the Foundation for Applied Medical Research (FIMA) is pleased to announce that the proposal for the project entitled “Cooperación para la Investigación Transpirenaica en la Terapia Innovadora de la Leucemia (CITTIL) has been approved”. Both organisations involved, FIMA in Pamplona and INSERM in Toulouse, have defined as their principal objective the development and subsequent treatment for Acute Lymphoblastic Leukemia LLA). In order to foment this research and establish firm connections between the partners and also announce the progress of their work, the following website has been created: www.cittil.org.

CITTIL is the acronym of the title of the project "Partnership for Research in Trans-Pyrenean Innovative Therapy for Leukemia", set within the Operational Program for Regional Cooperation France-Spain-Andorra and funded by the European Regional Development Fund of the European Union.

1. J. Familiades, M. Bousquet, M. Lafage-Pochitaloff, M.C. Béné, K. Beldjord, J. De Vos, N. Dastugue, E. Coyaud, S. Struski, C. Quelen, N. Prade-Houdellier, S. Dobbelstein, J.M. Cayuela, J. Soulier, N. Grardel, C. Preudhomme, H. Cavé, O. Blanchet, V. Lhéritier, A. Delannoy, Y. Chalandon, N. Ifrah, A. Pigneux, P. Brousset, E.A. Macintyre, F. Huguet, H. Dombret, C. Broccardo and E. Delabesse. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study (2009). Leukemia.

2. J.A. Richter-Larrea, E.F. Robles, V. Fresquet, E. Beltran, A.J. Rullan, X. Agirre, M.J. Calasanz, C. Panizo, J. A. Richter, J.M. Hernandez, J. Roman-Gomez, F. Prosper, J. A. Martinez-Climent. Reversion of epigenetically-mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma (2010). Blood.

3. E. Coyaud, S. Struski, N. Prade, J. Familiades, R. Eichner, C. Quelen, M. Bousquet, F. Mugneret, P. Talmant, M.P. Pages, C. Lefebvre, D. Penther, E. Lippert, N. Nadal, S. Taviaux, B. Poppe, I. Luquet, L. Baranger, V. Eclache, I. Radford, C. Barin, M.J. lle Mozziconacci, M. Lafage-Pochitaloff, H. Antoine-Poirel, C. Charrin, C. Perot, C. Terre, P. Brousset, N. Dastugue and C. Broccardo. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study (2010). Lymphoid Neoplasia.